D. pteronyssinus (d1) IgE

What is D. pteronyssinus (d1) IgE?

This test measures IgE antibodies specific to Dermatophagoides pteronyssinus, the European house dust mite, to help identify allergic sensitization related to indoor dust exposure.

Dermatophagoides pteronyssinus is one of the most common house dust mite species worldwide, living in bedding, upholstery, and carpeting where it feeds on shed skin cells. D. pteronyssinus-specific IgE testing detects antibodies produced after exposure to its proteins, reflecting sensitization rather than confirming an active allergic reaction on its own. It is commonly ordered when nasal, eye, respiratory, or skin symptoms seem worse indoors or upon waking, patterns often linked to dust mite exposure. Results are interpreted alongside symptom history and other lab findings such as total IgE and eosinophil count, and are often assessed together with the related species Dermatophagoides farinae. It relates mainly to the immune and respiratory systems.

Lifestyle factors that influence this marker

• Use allergen-proof covers on mattresses and pillows
• Wash bedding weekly in hot water to reduce dust mite populations
• Reduce indoor humidity, since dust mites thrive in humid environments
• Vacuum regularly with a HEPA filter and minimize wall-to-wall carpeting where possible
• Prioritize consistent sleep, since rest supports overall immune regulation
• Avoid smoking and secondhand smoke, which can irritate sensitive airways
• Track symptoms in relation to bedding and indoor humidity changes

Tests often checked alongside this

• Total IgE — helps place this result in the context of overall antibody activity
• Eosinophil Count — often elevated alongside allergic sensitization
• Dermatophagoides farinae (D. farinae) IgE — the related dust mite species often sensitized together

How this can show up in how you look and feel

• Sneezing, nasal congestion, or a runny nose, often worse indoors or on waking
• Itchy, watery eyes
• Coughing or wheezing, particularly overnight or in dusty environments
• Skin itching or eczema-like flare-ups

What can affect this marker

• Age — sensitization patterns can shift across childhood and adulthood
• Indoor humidity and bedding- or home-cleaning habits, which affect exposure
• Medications such as immunosuppressants, which may lower antibody responses
• Infection or inflammation elsewhere in the body
• Lab-to-lab variability in testing methods

What to track over time

• Whether levels rise, fall, or stay stable with changes in dust mite exposure or avoidance measures
• How results align with indoor humidity and cleaning routines
• Whether repeat testing is considered if symptoms change over time

What to ask your doctor

• Does this result correlate with the symptoms I've been experiencing?
• Should other indoor allergens be tested alongside this one?
• Would checking total IgE or eosinophil count add useful context?
• What bedding or cleaning changes might help reduce my exposure?
• Could allergen immunotherapy be worth discussing?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.